Axsome Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Axsome Therapeutics has a total shareholder equity of $191.0M and total debt of $178.1M, which brings its debt-to-equity ratio to 93.2%. Its total assets and total liabilities are $588.2M and $397.3M respectively.
Key information
93.2%
Debt to equity ratio
US$178.07m
Debt
Interest coverage ratio | n/a |
Cash | US$386.19m |
Equity | US$190.98m |
Total liabilities | US$397.26m |
Total assets | US$588.24m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0HKF's short term assets ($504.3M) exceed its short term liabilities ($138.9M).
Long Term Liabilities: 0HKF's short term assets ($504.3M) exceed its long term liabilities ($258.4M).
Debt to Equity History and Analysis
Debt Level: 0HKF has more cash than its total debt.
Reducing Debt: 0HKF's debt to equity ratio has reduced from 736.8% to 93.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0HKF has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0HKF has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.